Table 1 Patient and tumor characteristics at baseline (n = 9)
Age, years, median (range) | 72 (37–83) |
Gender (male: female) | 8:1 |
ECOG performance status | |
 0 | 1 (11%) |
 1 | 8 (89%) |
Child–Pugh score |  |
 5 (class A) | 4 (45%) |
 6 (class A) | 3 (33%) |
 7 (class B) | 2 (22%) |
Etiology of HCC | |
 Hepatitis B virus (HBV) | 5 (56%) |
 Hepatitis C virus (HCV) | 1 (11%) |
 Non-HBV, non-HCV | 3 (33%) |
BCLC staging | Â |
 B | 1 (11%) |
 C | 8 (89%) |
Number of liver tumor(s) | |
 Single | 6 (67%) |
 Multiple | 3 (33%) |
Portal vein thrombosis | |
 Present | 3 (33%) |
 Absent | 6 (67%) |
Regional lymph node metastasis | |
 Present | 0 (0%) |
 Absent | 9 (100%) |
Distant metastasis | |
 Present | 1 (11%) |
 Absent | 8 (89%) |
Maximum diameter of liver tumor, cm, median (range) | 6.6 (2.3–12.3) |
RT doses, Gy, median (range) | 45 (37.5–53) |